This inventor holds 1 USPTO granted patent. Top assignee: Merz+co. Gmbh & Co.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovations of Heinz Junglas
Introduction
Heinz Junglas is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on BHT ether compounds. His research focuses on the development of hypolipidemic agents that can have a profound impact on health.
Latest Patents
Heinz Junglas holds 1 patent for his invention titled "New BHT ether compounds and their use as hypolipidemic and - Pharmaceutically-active BHT-omega pyridyl ethers." This patent includes compounds of the formula selected from BHT-omega-pyridyl ether compounds, which are designed to provide therapeutic benefits.
Career Highlights
Heinz Junglas is currently employed at Merz+Co. GmbH & Co., where he continues to advance his research and development efforts. His work has been instrumental in creating new pharmaceutical solutions that address various health issues.
Collaborations
Heinz has collaborated with esteemed colleagues such as Markus R Gold and Panayiotis Jarglis. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in the pharmaceutical industry.
Conclusion
Heinz Junglas is a prominent figure in the field of pharmaceutical innovation, with a focus on developing effective hypolipidemic agents. His contributions through patents and collaborations continue to shape the future of health-related inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile